The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/. The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.
A 21-hydroxy steroid that consists of pregn-4-ene substituted by hydroxy groups at positions 11 and 21 and oxo groups at positions 3 and 20. Corticosterone is a 21-carbon steroid hormone of the corticosteroid type produced in the cortex of the adrenal glands.
Corticosterone results in decreased expression of ACAN mRNA Mifepristone inhibits the reaction [Corticosterone results in decreased expression of ACAN mRNA]
Corticosterone results in increased expression of ACE mRNA Corticosterone results in decreased methylation of ACE promoter Mifepristone inhibits the reaction [Corticosterone results in increased expression of ACE mRNA]
[Corticosterone co-treated with Physostigmine] results in decreased activity of ACHE protein; ACHE protein inhibits the reaction [Paraoxon results in increased abundance of Corticosterone]; Corticosterone inhibits the reaction [Isoflurophate results in decreased activity of ACHE protein]; Corticosterone inhibits the reaction [O,O-diethyl O-3,5,6-trichloro-2-pyridyl phosphate results in decreased activity of ACHE protein]
[Corticosterone co-treated with Rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of and results in increased secretion of ADIPOQ protein Corticosterone results in increased expression of ADIPOQ mRNA
Mifepristone inhibits the reaction [Corticosterone results in increased expression of AGTR1A mRNA] Corticosterone results in decreased expression of AGTR1A mRNA
Mifepristone inhibits the reaction [Corticosterone results in increased expression of AGTR2 mRNA] Corticosterone results in decreased expression of AGTR2 mRNA
[Testosterone co-treated with Estradiol co-treated with Corticosterone] promotes the reaction [AR protein binds to TRAF6 protein]; Corticosterone binds to and results in increased activity of AR protein mutant form; Corticosterone inhibits the reaction [Metribolone results in increased activity of AR protein]; Corticosterone inhibits the reaction [Stanozolol binds to and results in increased activity of AR protein] Corticosterone binds to AR protein Corticosterone results in increased activity of AR protein
Corticosterone results in decreased expression of ARRB1 mRNA Fluoxetine inhibits the reaction [Corticosterone results in decreased expression of ARRB1 mRNA]
Corticosterone results in decreased expression of ARRB2 mRNA Fluoxetine inhibits the reaction [Corticosterone results in decreased expression of ARRB2 mRNA]
Corticosterone results in increased expression of BAX protein Estradiol inhibits the reaction [Corticosterone results in increased expression of BAX protein]; Estradiol promotes the reaction [Testosterone inhibits the reaction [Corticosterone results in increased expression of BAX protein]]; so-ochim-tang-gamibang affects the reaction [Corticosterone affects the expression of BAX mRNA]; Testosterone inhibits the reaction [Corticosterone results in increased expression of BAX protein]; Testosterone promotes the reaction [Estradiol inhibits the reaction [Corticosterone results in increased expression of BAX protein]]
Estradiol inhibits the reaction [Corticosterone results in decreased expression of BCL2 protein]; Estradiol promotes the reaction [Testosterone inhibits the reaction [Corticosterone results in decreased expression of BCL2 protein]]; so-ochim-tang-gamibang affects the reaction [Corticosterone affects the expression of BCL2 mRNA]; Testosterone inhibits the reaction [Corticosterone results in decreased expression of BCL2 protein]; Testosterone promotes the reaction [Estradiol inhibits the reaction [Corticosterone results in decreased expression of BCL2 protein]]
[Corticosterone results in increased expression of BCL2L1 protein] which results in decreased susceptibility to Doxorubicin; BCL2L1 protein affects the reaction [Corticosterone results in decreased susceptibility to Doxorubicin]; JUN protein affects the reaction [Corticosterone results in increased expression of BCL2L1 mRNA]; Mifepristone inhibits the reaction [Corticosterone results in increased expression of BCL2L1 protein] Corticosterone results in increased expression of BCL2L1 mRNA; Corticosterone results in increased expression of BCL2L1 protein
Corticosterone results in decreased expression of BDNF protein 2-(3,4-dimethoxybenzyl)-7-(1-(1-hydroxyethyl)-4-phenylbutyl)-5-methylimidazo(5,1-f)(1,2,4)triazin-4 (3H)-one inhibits the reaction [Corticosterone results in decreased expression of BDNF protein]; KT 5823 inhibits the reaction [2-(3,4-dimethoxybenzyl)-7-(1-(1-hydroxyethyl)-4-phenylbutyl)-5-methylimidazo(5,1-f)(1,2,4)triazin-4 (3H)-one inhibits the reaction [Corticosterone results in decreased expression of BDNF protein]] Corticosterone results in decreased expression of BDNF mRNA O-1602 compound affects the reaction [Corticosterone affects the expression of BDNF protein]; so-ochim-tang-gamibang inhibits the reaction [Corticosterone results in decreased expression of BDNF mRNA]
Corticosterone results in decreased expression of BGLAP mRNA Enalapril inhibits the reaction [Corticosterone results in decreased expression of BGLAP mRNA]
CALCA protein results in increased abundance of Corticosterone O-1602 compound inhibits the reaction [Corticosterone results in increased expression of CALCA protein]
CARTPT protein results in increased abundance of Corticosterone astressin B inhibits the reaction [CARTPT protein results in increased abundance of Corticosterone]
Corticosterone inhibits the reaction [Deoxyglucose results in increased activity of CASP3 protein]; Corticosterone inhibits the reaction [Doxorubicin results in increased activity of CASP3 protein]; Corticosterone inhibits the reaction [Palmitates results in increased activity of CASP3 protein]; Estradiol inhibits the reaction [Corticosterone results in increased cleavage of CASP3 protein]; Estradiol promotes the reaction [Testosterone inhibits the reaction [Corticosterone results in increased cleavage of CASP3 protein]]; Mifepristone inhibits the reaction [Corticosterone inhibits the reaction [Doxorubicin results in increased activity of CASP3 protein]]; so-ochim-tang-gamibang inhibits the reaction [Corticosterone results in increased expression of CASP3 mRNA]; Testosterone inhibits the reaction [Corticosterone results in increased cleavage of CASP3 protein]; Testosterone promotes the reaction [Estradiol inhibits the reaction [Corticosterone results in increased cleavage of CASP3 protein]]
Estradiol inhibits the reaction [Corticosterone results in increased cleavage of CASP8 protein]; Estradiol promotes the reaction [Testosterone inhibits the reaction [Corticosterone results in increased cleavage of CASP8 protein]]; Testosterone inhibits the reaction [Corticosterone results in increased cleavage of CASP8 protein]; Testosterone promotes the reaction [Estradiol inhibits the reaction [Corticosterone results in increased cleavage of CASP8 protein]]
Corticosterone results in increased activity of CAT protein Clozapine inhibits the reaction [Corticosterone results in increased activity of CAT protein]; Clozapine inhibits the reaction [Lipopolysaccharides inhibits the reaction [Corticosterone results in increased activity of CAT protein]]; Lipopolysaccharides inhibits the reaction [Corticosterone results in increased activity of CAT protein]; Sulpiride promotes the reaction [Lipopolysaccharides inhibits the reaction [Corticosterone results in increased activity of CAT protein]]
Corticosterone results in decreased expression of CCL2 mRNA Corticosterone promotes the reaction [Isoflurophate results in increased expression of CCL2 mRNA] [Corticosterone co-treated with Isoflurophate] results in increased expression of CCL2 mRNA; [Corticosterone co-treated with O,O-diethyl O-3,5,6-trichloro-2-pyridyl phosphate] results in increased expression of CCL2 mRNA; [Permethrin co-treated with Pyridostigmine Bromide co-treated with Corticosterone] results in increased expression of CCL2 mRNA; Butyric Acid inhibits the reaction [[Permethrin co-treated with Pyridostigmine Bromide co-treated with Corticosterone] results in increased expression of CCL2 mRNA]; Corticosterone promotes the reaction [Isoflurophate results in increased expression of CCL2 mRNA]; Corticosterone promotes the reaction [O,O-diethyl O-3,5,6-trichloro-2-pyridyl phosphate results in increased expression of CCL2 mRNA]; Physostigmine inhibits the reaction [Corticosterone results in decreased expression of CCL2 mRNA]
[Permethrin co-treated with Pyridostigmine Bromide co-treated with Corticosterone] results in increased expression of CD68 mRNA; Butyric Acid inhibits the reaction [[Permethrin co-treated with Pyridostigmine Bromide co-treated with Corticosterone] results in increased expression of CD68 mRNA]
[Corticosterone results in increased phosphorylation of NDRG1 protein] which results in increased expression of and results in increased localization of CDH2 protein
Corticosterone promotes the reaction [CDKN1A protein binds to CDK2 protein] Corticosterone results in decreased activity of CDK2 protein Corticosterone results in decreased expression of CDK2 protein
Corticosterone inhibits the reaction [CDKN1A protein binds to CDK4 protein]; Corticosterone promotes the reaction [CDKN1B protein binds to CDK4 protein] Corticosterone results in decreased expression of CDK4 protein Corticosterone results in decreased activity of CDK4 protein
Corticosterone affects the expression of CDKN1A protein Corticosterone inhibits the reaction [CDKN1A protein binds to CDK4 protein]; Corticosterone promotes the reaction [CDKN1A protein binds to CDK2 protein]
Corticosterone results in increased expression of CEBPB mRNA CEBPB protein affects the reaction [Corticosterone results in increased expression of PTGS2 mRNA]; CEBPB protein affects the reaction [Corticosterone results in increased expression of PTGS2 protein]; Corticosterone promotes the reaction [CEBPB protein binds to PTGS2 promoter]
Corticosterone results in decreased expression of COL2A1 mRNA; Corticosterone results in decreased expression of COL2A1 protein Mifepristone inhibits the reaction [Corticosterone results in decreased expression of COL2A1 mRNA]
2-(3,4-dimethoxybenzyl)-7-(1-(1-hydroxyethyl)-4-phenylbutyl)-5-methylimidazo(5,1-f)(1,2,4)triazin-4 (3H)-one inhibits the reaction [Corticosterone results in decreased expression of CREBBP protein]; KT 5823 inhibits the reaction [2-(3,4-dimethoxybenzyl)-7-(1-(1-hydroxyethyl)-4-phenylbutyl)-5-methylimidazo(5,1-f)(1,2,4)triazin-4 (3H)-one inhibits the reaction [Corticosterone results in decreased expression of CREBBP protein]]
Astemizole inhibits the reaction [Corticosterone inhibits the reaction [CRH protein results in increased secretion of Adrenocorticotropic Hormone]]; Corticosterone affects the reaction [Nitroprusside results in increased secretion of CRH protein]; Corticosterone inhibits the reaction [CRH protein results in increased secretion of Adrenocorticotropic Hormone]; E 4031 inhibits the reaction [Corticosterone inhibits the reaction [CRH protein results in increased secretion of Adrenocorticotropic Hormone]]; O-1602 compound inhibits the reaction [Corticosterone results in increased expression of CRH protein] CRH protein affects the reaction [[DUSP8 protein affects the susceptibility to Dietary Fats] which affects the abundance of Corticosterone] Corticosterone results in decreased expression of CRH mRNA Corticosterone results in increased expression of CRH mRNA; Corticosterone results in increased expression of CRH protein Corticosterone affects the expression of CRH mRNA CRH protein results in increased abundance of Corticosterone
[Corticosterone results in increased phosphorylation of NDRG1 protein] which results in increased expression of and results in increased localization of CTNNA1 protein
[Corticosterone results in increased phosphorylation of NDRG1 protein] promotes the reaction [NDRG1 protein binds to CTNNB1 protein]; [Corticosterone results in increased phosphorylation of NDRG1 protein] which results in increased expression of and results in increased localization of CTNNB1 protein
CYP11B2 protein affects the metabolism of Corticosterone [CYP11B2 protein results in increased hydroxylation of Corticosterone] which results in increased chemical synthesis of Aldosterone; [CYP11B2 protein results in increased hydroxylation of Desoxycorticosterone] which results in increased chemical synthesis of Corticosterone CYP11B2 protein results in increased chemical synthesis of Corticosterone
Corticosterone promotes the reaction [Ethanol results in increased expression of CYP1A2 mRNA] Corticosterone results in increased expression of CYP1A2 mRNA
Corticosterone results in increased expression of CYP2B1 mRNA; Corticosterone results in increased expression of CYP2B1 protein Corticosterone promotes the reaction [Ethanol results in increased expression of CYP2B1 protein]
Corticosterone promotes the reaction [Ethanol results in increased expression of CYP2B6 mRNA] Corticosterone results in increased expression of CYP2B6 mRNA; Corticosterone results in increased expression of CYP2B6 protein
Corticosterone results in increased expression of CYP2D4 mRNA Corticosterone promotes the reaction [Ethanol results in increased expression of CYP2D6 mRNA] Corticosterone results in increased expression of CYP2D6 mRNA
Corticosterone results in increased expression of CYP2E1 mRNA; Corticosterone results in increased expression of CYP2E1 protein Corticosterone promotes the reaction [Ethanol results in increased expression of CYP2E1 mRNA]
[Corticosterone binds to CYP3A4 promoter] which results in increased expression of CYP3A4 mRNA; Corticosterone promotes the reaction [[NCOA1 protein binds to NR1I2 protein] which results in increased expression of CYP3A4 mRNA]; Corticosterone promotes the reaction [NR1I2 protein results in increased expression of CYP3A4 mRNA]; Ketoconazole inhibits the reaction [Corticosterone promotes the reaction [NR1I2 protein results in increased expression of CYP3A4 mRNA]]; Ketoconazole inhibits the reaction [Corticosterone results in increased expression of CYP3A4 mRNA] Corticosterone results in increased expression of CYP3A4 mRNA; Corticosterone results in increased expression of CYP3A4 protein
Corticosterone promotes the reaction [Ethanol results in increased expression of CYP3A23-3A1 mRNA] Corticosterone results in increased expression of CYP3A23-3A1 mRNA; Corticosterone results in increased expression of CYP3A23-3A1 protein
Corticosterone results in increased expression of DKK1 protein Mifepristone inhibits the reaction [Corticosterone results in increased expression of DKK1 protein]; NR3C1 protein promotes the reaction [Corticosterone results in increased expression of DKK1 protein]
Corticosterone results in decreased expression of DLG4 protein Ascorbic Acid inhibits the reaction [Corticosterone results in decreased expression of DLG4 protein]; Ketamine inhibits the reaction [Corticosterone results in decreased expression of DLG4 protein]
[DUSP8 protein affects the susceptibility to Dietary Fats] which affects the abundance of Corticosterone; CRH protein affects the reaction [[DUSP8 protein affects the susceptibility to Dietary Fats] which affects the abundance of Corticosterone]; Dexamethasone affects the reaction [[DUSP8 protein affects the susceptibility to Dietary Fats] which affects the abundance of Corticosterone]
Corticosterone results in increased activity of FAAH protein antalarmin inhibits the reaction [Corticosterone results in increased activity of FAAH protein]
[Corticosterone co-treated with Rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of FABP4 protein; Corticosterone inhibits the reaction [[Dexamethasone co-treated with Rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of FABP4 protein]
Corticosterone results in decreased expression of FKBP5 mRNA Edaravone inhibits the reaction [Corticosterone results in decreased expression of FKBP5 mRNA]
GAD1 affects the reaction [2,5-dihydro-2,4,5-trimethylthiazoline results in increased secretion of Corticosterone] Corticosterone results in increased expression of GAD1 mRNA
Corticosterone results in decreased expression of GNAI2 mRNA Fluoxetine inhibits the reaction [Corticosterone results in decreased expression of GNAI2 mRNA]
Corticosterone results in decreased expression of GRIA1 protein Ketamine inhibits the reaction [Corticosterone results in decreased expression of GRIA1 protein]
HDAC7 protein affects the reaction [Corticosterone results in decreased expression of KLF4 mRNA]; HDAC7 protein affects the reaction [Corticosterone results in decreased expression of KLF4 protein]; HDAC7 protein affects the reaction [Corticosterone results in decreased expression of NPHS1 mRNA]; HDAC7 protein affects the reaction [Corticosterone results in decreased expression of NPHS1 protein]; Mifepristone inhibits the reaction [Corticosterone results in increased expression of HDAC7 mRNA]; Mifepristone inhibits the reaction [Corticosterone results in increased expression of HDAC7 protein] Corticosterone results in increased expression of HDAC7 mRNA; Corticosterone results in increased expression of HDAC7 protein
[Permethrin co-treated with Pyridostigmine Bromide co-treated with Corticosterone] results in increased secretion of HMGB1 protein; Butyric Acid inhibits the reaction [[Permethrin co-treated with Pyridostigmine Bromide co-treated with Corticosterone] results in increased secretion of HMGB1 protein]
HSD11B1 protein results in increased chemical synthesis of Corticosterone [[trimethyltin chloride results in increased abundance of trimethyltin] which co-treated with Corticosterone] results in increased expression of HSD11B1 mRNA; Corticosterone promotes the reaction [[trimethyltin chloride results in increased abundance of trimethyltin] which results in increased expression of HSD11B1 mRNA]; Mifepristone inhibits the reaction [Corticosterone promotes the reaction [[trimethyltin chloride results in increased abundance of trimethyltin] which results in increased expression of HSD11B1 mRNA]]; Spironolactone inhibits the reaction [Corticosterone promotes the reaction [[trimethyltin chloride results in increased abundance of trimethyltin] which results in increased expression of HSD11B1 mRNA]] HSD11B1 protein results in increased oxidation of Corticosterone HSD11B1 gene mutant form results in decreased abundance of Corticosterone [HSD11B1 protein results in increased oxidation of Corticosterone] which results in increased chemical synthesis of 11-dehydrocorticosterone; [HSD11B1 protein results in increased reduction of 11-dehydrocorticosterone] which results in increased chemical synthesis of Corticosterone; resveratrol inhibits the reaction [HSD11B1 protein results in increased chemical synthesis of Corticosterone]; Ziram inhibits the reaction [[HSD11B1 protein results in increased reduction of 11-dehydrocorticosterone] which results in increased chemical synthesis of Corticosterone] Corticosterone results in increased expression of HSD11B1 mRNA
[HSD11B2 protein results in increased metabolism of Corticosterone] which results in increased chemical synthesis of 11-dehydrocorticosterone; [HSD11B2 protein results in increased oxidation of Corticosterone] which results in increased chemical synthesis of 11-dehydrocorticosterone; Betamethasone inhibits the reaction [HSD11B2 protein affects the metabolism of Corticosterone]; Dexamethasone inhibits the reaction [HSD11B2 protein affects the metabolism of Corticosterone]; Ziram inhibits the reaction [[HSD11B2 protein results in increased oxidation of Corticosterone] which results in increased chemical synthesis of 11-dehydrocorticosterone]; Ziram inhibits the reaction [HSD11B2 protein results in increased oxidation of Corticosterone]
[alpha-cyano-(3,4-dihydroxy)-N-benzylcinnamide results in decreased activity of JAK2 protein] inhibits the reaction [HTR2A protein results in increased secretion of Corticosterone]; [Ketanserin binds to and results in decreased activity of HTR2A protein] inhibits the reaction [Methamphetamine results in increased secretion of Corticosterone] Corticosterone results in increased expression of HTR2A mRNA
Corticosterone results in decreased expression of IGF1 mRNA; Corticosterone results in decreased expression of IGF1 protein 2-(2-chloro-4-iodophenylamino)-N-cyclopropylmethoxy-3,4-difluoro-5-bromobenzamide inhibits the reaction [IGF1 protein inhibits the reaction [Corticosterone results in decreased expression of IGF1 mRNA]]; 2-(2-chloro-4-iodophenylamino)-N-cyclopropylmethoxy-3,4-difluoro-5-bromobenzamide inhibits the reaction [IGF1 protein inhibits the reaction [Corticosterone results in decreased expression of PCNA mRNA]]; 2-(2-chloro-4-iodophenylamino)-N-cyclopropylmethoxy-3,4-difluoro-5-bromobenzamide inhibits the reaction [IGF1 protein inhibits the reaction [Corticosterone results in decreased phosphorylation of MAPK1 protein]]; 2-(2-chloro-4-iodophenylamino)-N-cyclopropylmethoxy-3,4-difluoro-5-bromobenzamide inhibits the reaction [IGF1 protein inhibits the reaction [Corticosterone results in decreased phosphorylation of MAPK3 protein]]; IGF1 protein inhibits the reaction [Corticosterone results in decreased expression of IGF1 mRNA]; IGF1 protein inhibits the reaction [Corticosterone results in decreased expression of PCNA mRNA]; IGF1 protein inhibits the reaction [Corticosterone results in decreased phosphorylation of MAPK1 protein]; IGF1 protein inhibits the reaction [Corticosterone results in decreased phosphorylation of MAPK3 protein] Corticosterone results in increased expression of IGF1 mRNA
Corticosterone results in decreased expression of IGF1R mRNA; Corticosterone results in decreased expression of IGF1R protein [IGF2R protein co-treated with IGF1R protein] affects the reaction [IGF2 protein inhibits the reaction [Corticosterone results in decreased expression of SOD2 protein]]
[IGF2R protein co-treated with IGF1R protein] affects the reaction [IGF2 protein inhibits the reaction [Corticosterone results in decreased expression of SOD2 protein]]; IGF2 protein inhibits the reaction [Corticosterone results in decreased expression of SOD2 protein]
[IGF2R protein co-treated with IGF1R protein] affects the reaction [IGF2 protein inhibits the reaction [Corticosterone results in decreased expression of SOD2 protein]]
IL1B protein results in increased chemical synthesis of Corticosterone Corticosterone results in increased expression of IL1B mRNA Corticosterone affects the expression of IL1B mRNA Corticosterone results in increased expression of IL1B mRNA; Corticosterone results in increased expression of IL1B protein [Corticosterone co-treated with Isoflurophate] results in increased expression of IL1B mRNA; [Corticosterone co-treated with O,O-diethyl O-3,5,6-trichloro-2-pyridyl phosphate] results in increased expression of IL1B mRNA; [Permethrin co-treated with Pyridostigmine Bromide co-treated with Corticosterone] results in increased expression of and results in increased secretion of IL1B protein; [Permethrin co-treated with Pyridostigmine Bromide co-treated with Corticosterone] results in increased expression of IL1B mRNA; Butyric Acid inhibits the reaction [[Permethrin co-treated with Pyridostigmine Bromide co-treated with Corticosterone] results in increased expression of and results in increased secretion of IL1B protein]; Butyric Acid inhibits the reaction [[Permethrin co-treated with Pyridostigmine Bromide co-treated with Corticosterone] results in increased expression of IL1B mRNA]; O,O-diethyl O-3,5,6-trichloro-2-pyridyl phosphate affects the reaction [Corticosterone affects the expression of IL1B mRNA]; Physostigmine affects the reaction [Corticosterone affects the expression of IL1B mRNA] Corticosterone promotes the reaction [Isoflurophate results in increased expression of IL1B mRNA]; Ketorolac inhibits the reaction [IL1B protein results in increased secretion of Corticosterone]; O-1602 compound inhibits the reaction [Corticosterone results in increased expression of IL1B protein] [Finasteride results in increased susceptibility to IL1B protein] which results in increased secretion of Corticosterone
Corticosterone inhibits the reaction [Isoflurophate results in increased expression of IL6 mRNA] Corticosterone results in decreased expression of IL6 mRNA [Corticosterone co-treated with Physostigmine] results in decreased expression of IL6 mRNA; [Pyridostigmine Bromide co-treated with Corticosterone] results in decreased expression of IL6 mRNA; Corticosterone inhibits the reaction [O,O-diethyl O-3,5,6-trichloro-2-pyridyl phosphate results in decreased expression of IL6 mRNA]; Corticosterone promotes the reaction [[trimethyltin chloride results in increased abundance of trimethyltin] which results in increased expression of IL6 mRNA]; Isoflurophate inhibits the reaction [Corticosterone results in decreased expression of IL6 mRNA]; O,O-diethyl O-3,5,6-trichloro-2-pyridyl phosphate inhibits the reaction [Corticosterone results in decreased expression of IL6 mRNA]; Spironolactone inhibits the reaction [Corticosterone promotes the reaction [[trimethyltin chloride results in increased abundance of trimethyltin] which results in increased expression of IL6 mRNA]] Corticosterone results in increased expression of IL6 mRNA
[Corticosterone co-treated with Rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of and results in increased secretion of ADIPOQ protein; [Corticosterone co-treated with Rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of FABP4 protein; Corticosterone inhibits the reaction [[Dexamethasone co-treated with Rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of FABP4 protein]
[alpha-cyano-(3,4-dihydroxy)-N-benzylcinnamide results in decreased activity of JAK2 protein] inhibits the reaction [HTR2A protein results in increased secretion of Corticosterone]
1,2-bis(2-aminophenoxy)ethane N,N,N',N'-tetraacetic acid acetoxymethyl ester inhibits the reaction [Corticosterone results in decreased expression of KDR protein]; Calcium promotes the reaction [Corticosterone results in decreased expression of KDR protein]; Corticosterone inhibits the reaction [KDR protein binds to NR3C1 protein]; Mifepristone inhibits the reaction [Corticosterone results in decreased expression of KDR protein]; NR3C1 protein promotes the reaction [Corticosterone results in decreased expression of KDR protein]
HDAC7 protein affects the reaction [Corticosterone results in decreased expression of KLF4 mRNA]; HDAC7 protein affects the reaction [Corticosterone results in decreased expression of KLF4 protein]; KLF4 protein inhibits the reaction [Corticosterone results in decreased expression of NPHS1 mRNA]; KLF4 protein inhibits the reaction [Corticosterone results in decreased expression of NPHS1 protein]; Mifepristone inhibits the reaction [Corticosterone results in decreased expression of KLF4 mRNA]; Mifepristone inhibits the reaction [Corticosterone results in decreased expression of KLF4 protein]; trichostatin A inhibits the reaction [Corticosterone results in decreased expression of KLF4 mRNA]; trichostatin A inhibits the reaction [Corticosterone results in decreased expression of KLF4 protein] Corticosterone results in decreased expression of KLF4 mRNA; Corticosterone results in decreased expression of KLF4 protein
1-(3-chlorophenyl)piperazine inhibits the reaction [Corticosterone results in decreased expression of LEP protein]; 8-(5-(5-amino-2,4-dimethoxyphenyl)-5-oxopentyl)-1,3,8-triazaspiro(4.5)decane-2,4-dione inhibits the reaction [1-(3-chlorophenyl)piperazine inhibits the reaction [Corticosterone results in decreased expression of LEP protein]]; [Permethrin co-treated with Pyridostigmine Bromide co-treated with Corticosterone] results in increased secretion of LEP protein; Butyric Acid inhibits the reaction [[Permethrin co-treated with Pyridostigmine Bromide co-treated with Corticosterone] results in increased secretion of LEP protein]
[Corticosterone co-treated with Isoflurophate] results in increased expression of LIF mRNA [Corticosterone co-treated with Isoflurophate] results in increased expression of LIF mRNA; [Corticosterone co-treated with O,O-diethyl O-3,5,6-trichloro-2-pyridyl phosphate] results in increased expression of LIF mRNA; [Corticosterone co-treated with Physostigmine] results in decreased expression of LIF mRNA Corticosterone results in decreased expression of LIF mRNA
LRRK2 protein mutant form promotes the reaction [Paraquat results in increased secretion of Corticosterone] LRRK2 protein mutant form results in increased secretion of Corticosterone; LRRK2 protein results in increased secretion of Corticosterone
1,3-bis(4-hydroxyphenyl)-4-methyl-5-(4-(2-piperidinylethoxy)phenol)-1H-pyrazole inhibits the reaction [Estradiol inhibits the reaction [Corticosterone results in increased phosphorylation of MAP3K7 protein]]; Estradiol inhibits the reaction [Corticosterone results in increased phosphorylation of MAP3K7 protein]; Flutamide inhibits the reaction [Estradiol inhibits the reaction [Corticosterone results in increased phosphorylation of MAP3K7 protein]]; Testosterone promotes the reaction [Estradiol inhibits the reaction [Corticosterone results in increased phosphorylation of MAP3K7 protein]]
Corticosterone results in increased phosphorylation of MAPK1 protein Corticosterone results in decreased phosphorylation of MAPK1 protein 2-(3,4-dimethoxybenzyl)-7-(1-(1-hydroxyethyl)-4-phenylbutyl)-5-methylimidazo(5,1-f)(1,2,4)triazin-4 (3H)-one inhibits the reaction [Corticosterone results in increased phosphorylation of MAPK1 protein]; KT 5823 inhibits the reaction [2-(3,4-dimethoxybenzyl)-7-(1-(1-hydroxyethyl)-4-phenylbutyl)-5-methylimidazo(5,1-f)(1,2,4)triazin-4 (3H)-one inhibits the reaction [Corticosterone results in increased phosphorylation of MAPK1 protein]] Corticosterone results in decreased activity of MAPK1 protein 2-(2-chloro-4-iodophenylamino)-N-cyclopropylmethoxy-3,4-difluoro-5-bromobenzamide inhibits the reaction [IGF1 protein inhibits the reaction [Corticosterone results in decreased phosphorylation of MAPK1 protein]]; Curcumin inhibits the reaction [Corticosterone results in increased phosphorylation of MAPK1 protein]; IGF1 protein inhibits the reaction [Corticosterone results in decreased phosphorylation of MAPK1 protein]
Corticosterone results in increased phosphorylation of MAPK3 protein Corticosterone results in decreased phosphorylation of MAPK3 protein 2-(3,4-dimethoxybenzyl)-7-(1-(1-hydroxyethyl)-4-phenylbutyl)-5-methylimidazo(5,1-f)(1,2,4)triazin-4 (3H)-one inhibits the reaction [Corticosterone results in increased phosphorylation of MAPK3 protein]; KT 5823 inhibits the reaction [2-(3,4-dimethoxybenzyl)-7-(1-(1-hydroxyethyl)-4-phenylbutyl)-5-methylimidazo(5,1-f)(1,2,4)triazin-4 (3H)-one inhibits the reaction [Corticosterone results in increased phosphorylation of MAPK3 protein]] Corticosterone results in decreased activity of MAPK3 protein 2-(2-chloro-4-iodophenylamino)-N-cyclopropylmethoxy-3,4-difluoro-5-bromobenzamide inhibits the reaction [IGF1 protein inhibits the reaction [Corticosterone results in decreased phosphorylation of MAPK3 protein]]; Curcumin inhibits the reaction [Corticosterone results in increased phosphorylation of MAPK3 protein]; IGF1 protein inhibits the reaction [Corticosterone results in decreased phosphorylation of MAPK3 protein]
MC2R protein promotes the reaction [PRL protein results in increased secretion of Corticosterone]; PRL protein promotes the reaction [MC2R protein results in increased secretion of Corticosterone]
[Corticosterone results in increased phosphorylation of NDRG1 protein] promotes the reaction [NDRG1 protein binds to CTNNB1 protein]; [Corticosterone results in increased phosphorylation of NDRG1 protein] which results in increased expression of and results in increased localization of CDH2 protein; [Corticosterone results in increased phosphorylation of NDRG1 protein] which results in increased expression of and results in increased localization of CTNNA1 protein; [Corticosterone results in increased phosphorylation of NDRG1 protein] which results in increased expression of and results in increased localization of CTNNB1 protein [Corticosterone results in increased phosphorylation of SGK1 protein] which results in increased phosphorylation of NDRG1 protein
Corticosterone results in decreased expression of NGF protein O-1602 compound inhibits the reaction [Corticosterone results in decreased expression of NGF protein]
Corticosterone results in increased expression of NPPA mRNA Corticosterone promotes the reaction [Phenylephrine results in increased expression of NPPA mRNA]
Corticosterone binds to and results in increased activity of NR1I2 protein; Corticosterone promotes the reaction [[NCOA1 protein binds to NR1I2 protein] which results in increased expression of CYP3A4 mRNA]; Corticosterone promotes the reaction [NR1I2 protein results in increased expression of CYP3A4 mRNA]; Ketoconazole inhibits the reaction [Corticosterone promotes the reaction [NR1I2 protein results in increased expression of CYP3A4 mRNA]]
Corticosterone binds to and results in increased activity of NR1I3 protein; Corticosterone inhibits the reaction [Androstane-3,17-diol binds to and results in decreased activity of NR1I3 protein]
Corticosterone binds to and results in increased activity of NR3C1 protein Corticosterone binds to NR3C1 protein Corticosterone results in increased activity of NR3C1 protein 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one promotes the reaction [Carbamazepine inhibits the reaction [Corticosterone results in increased activity of NR3C1 protein]]; 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one promotes the reaction [Lithium inhibits the reaction [Corticosterone results in increased activity of NR3C1 protein]]; 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one promotes the reaction [Valproic Acid inhibits the reaction [Corticosterone results in increased activity of NR3C1 protein]]; Carbamazepine inhibits the reaction [Corticosterone results in increased activity of NR3C1 protein]; Chlorpromazine inhibits the reaction [Corticosterone results in increased activity of NR3C1 protein]; Clozapine inhibits the reaction [Corticosterone results in increased activity of NR3C1 protein]; Corticosterone inhibits the reaction [KDR protein binds to NR3C1 protein]; Lithium inhibits the reaction [Corticosterone results in increased activity of NR3C1 protein]; Mifepristone inhibits the reaction [Corticosterone results in decreased expression of NR3C1 protein]; Mifepristone inhibits the reaction [Corticosterone results in increased activity of NR3C1 protein]; NR3C1 protein promotes the reaction [Corticosterone results in decreased expression of KDR protein]; NR3C1 protein promotes the reaction [Corticosterone results in increased expression of DKK1 protein]; Pregnanolone analog inhibits the reaction [Corticosterone results in increased activity of NR3C1 protein]; Pregnanolone inhibits the reaction [Corticosterone results in increased activity of NR3C1 protein]; pyrazolanthrone inhibits the reaction [Valproic Acid inhibits the reaction [Corticosterone results in increased activity of NR3C1 protein]]; Valproic Acid inhibits the reaction [Corticosterone results in increased activity of NR3C1 protein] NR3C1 protein affects the abundance of Corticosterone [Mifepristone binds to and results in decreased activity of NR3C1 protein] inhibits the reaction [Corticosterone results in increased expression of PTGS2 mRNA]; [Mifepristone binds to and results in decreased activity of NR3C1 protein] inhibits the reaction [Corticosterone results in increased expression of PTGS2 protein]; Corticosterone promotes the reaction [[NR3C1 protein binds to TAT promoter] which results in increased expression of TAT mRNA]; Corticosterone promotes the reaction [NR3C1 protein binds to PTGS2 promoter]; Lead inhibits the reaction [Corticosterone binds to NR3C1 protein]; Mifepristone inhibits the reaction [Corticosterone promotes the reaction [NR3C1 protein binds to PTGS2 promoter]] Corticosterone affects the localization of NR3C1 protein Corticosterone results in increased expression of NR3C1 mRNA Corticosterone results in increased expression of NR3C1 mRNA; Corticosterone results in increased expression of NR3C1 protein
[Permethrin co-treated with Pyridostigmine Bromide co-treated with Corticosterone] results in decreased expression of OCLN protein; Butyric Acid inhibits the reaction [[Permethrin co-treated with Pyridostigmine Bromide co-treated with Corticosterone] results in decreased expression of OCLN protein]
[Corticosterone co-treated with Isoflurophate] results in increased expression of OSM mRNA [Corticosterone co-treated with Isoflurophate] results in increased expression of OSM mRNA; [Corticosterone co-treated with Physostigmine] results in increased expression of OSM mRNA; Corticosterone promotes the reaction [O,O-diethyl O-3,5,6-trichloro-2-pyridyl phosphate results in increased expression of OSM mRNA]
Corticosterone results in decreased expression of PCNA mRNA; Corticosterone results in decreased expression of PCNA protein 2-(2-chloro-4-iodophenylamino)-N-cyclopropylmethoxy-3,4-difluoro-5-bromobenzamide inhibits the reaction [IGF1 protein inhibits the reaction [Corticosterone results in decreased expression of PCNA mRNA]]; IGF1 protein inhibits the reaction [Corticosterone results in decreased expression of PCNA mRNA]
Corticosterone results in increased expression of PDE2A mRNA; Corticosterone results in increased expression of PDE2A mRNA alternative form; Corticosterone results in increased expression of PDE2A protein Mifepristone inhibits the reaction [Corticosterone results in increased expression of PDE2A protein]
[Corticosterone results in increased phosphorylation of and results in increased activity of PDK1 protein] which results in increased phosphorylation of and results in increased activity of SGK1 protein; Corticosterone results in increased phosphorylation of and results in increased activity of PDK1 protein
Corticosterone inhibits the reaction [[Oxidopamine co-treated with Levodopa] results in increased expression of PDYN mRNA] PDYN protein promotes the reaction [Cocaine results in increased abundance of Corticosterone]
[Permethrin co-treated with Pyridostigmine Bromide co-treated with Corticosterone] results in increased expression of PFKP mRNA; Butyric Acid inhibits the reaction [[Permethrin co-treated with Pyridostigmine Bromide co-treated with Corticosterone] results in increased expression of PFKP mRNA]; TLR4 gene mutant form inhibits the reaction [[Permethrin co-treated with Pyridostigmine Bromide co-treated with Corticosterone] results in increased expression of PFKP mRNA]
Bromocriptine inhibits the reaction [POMC protein results in decreased secretion of Corticosterone]; Corticosterone inhibits the reaction [Nitroprusside results in increased secretion of POMC protein]; Cromolyn Sodium inhibits the reaction [POMC results in increased secretion of Corticosterone]; Fulvestrant inhibits the reaction [nonylphenol promotes the reaction [POMC protein modified form results in increased secretion of Corticosterone]]; Nitroprusside inhibits the reaction [POMC protein modified form results in increased secretion of Corticosterone]; nonylphenol inhibits the reaction [Nitroprusside inhibits the reaction [POMC protein modified form results in increased secretion of Corticosterone]]; nonylphenol promotes the reaction [POMC protein modified form results in increased secretion of Corticosterone]; oxophenylarsine inhibits the reaction [POMC protein results in increased abundance of Corticosterone]; pervanadate inhibits the reaction [POMC protein results in increased abundance of Corticosterone]; SB 203580 inhibits the reaction [POMC protein modified form results in increased secretion of Corticosterone] lipopolysaccharide, Escherichia coli O111 B4 inhibits the reaction [POMC protein modified form results in increased secretion of Corticosterone]; resveratrol inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 inhibits the reaction [POMC protein modified form results in increased secretion of Corticosterone]] POMC protein results in decreased abundance of Corticosterone POMC protein modified form results in increased secretion of Corticosterone; POMC protein results in increased secretion of Corticosterone; POMC results in increased secretion of Corticosterone Corticosterone results in decreased secretion of POMC protein; POMC protein results in decreased secretion of Corticosterone
[Permethrin co-treated with Pyridostigmine Bromide co-treated with Corticosterone] results in increased expression of PPARA mRNA; Butyric Acid inhibits the reaction [[Permethrin co-treated with Pyridostigmine Bromide co-treated with Corticosterone] results in increased expression of PPARA mRNA]; TLR4 gene mutant form inhibits the reaction [[Permethrin co-treated with Pyridostigmine Bromide co-treated with Corticosterone] results in increased expression of PPARA mRNA]
[Permethrin co-treated with Pyridostigmine Bromide co-treated with Corticosterone] results in decreased expression of PPARG mRNA; Butyric Acid inhibits the reaction [[Permethrin co-treated with Pyridostigmine Bromide co-treated with Corticosterone] results in decreased expression of PPARG mRNA]
[Androgens deficiency affects the activity of PRKAR1A gene mutant form] which results in increased secretion of Corticosterone; [PRKAR1A gene mutant form results in increased susceptibility to Androgens deficiency] which results in increased secretion of Corticosterone; Dexamethasone inhibits the reaction [[PRKAR1A gene mutant form results in increased susceptibility to Androgens deficiency] which results in increased secretion of Corticosterone]; Dexamethasone inhibits the reaction [PRKAR1A gene mutant form results in increased secretion of Corticosterone]; Dihydrotestosterone inhibits the reaction [[Androgens deficiency affects the activity of PRKAR1A gene mutant form] which results in increased secretion of Corticosterone]; Dihydrotestosterone inhibits the reaction [[PRKAR1A gene mutant form results in increased susceptibility to Androgens deficiency] which results in increased secretion of Corticosterone]
1-(6-((3-methoxyestra-1,3,5(10)-trien-17-yl)amino)hexyl)-1H-pyrrole-2,5-dione promotes the reaction [Corticosterone results in increased activity of PRKCA protein]; 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one promotes the reaction [Corticosterone results in increased activity of PRKCA protein]
MC2R protein promotes the reaction [PRL protein results in increased secretion of Corticosterone]; PRL protein promotes the reaction [MC2R protein results in increased secretion of Corticosterone]
[Mifepristone binds to and results in decreased activity of NR3C1 protein] inhibits the reaction [Corticosterone results in increased expression of PTGS2 mRNA]; [Mifepristone binds to and results in decreased activity of NR3C1 protein] inhibits the reaction [Corticosterone results in increased expression of PTGS2 protein]; CEBPB protein affects the reaction [Corticosterone results in increased expression of PTGS2 mRNA]; CEBPB protein affects the reaction [Corticosterone results in increased expression of PTGS2 protein]; Corticosterone promotes the reaction [CEBPB protein binds to PTGS2 promoter]; Corticosterone promotes the reaction [NR3C1 protein binds to PTGS2 promoter]; Dactinomycin inhibits the reaction [Corticosterone results in increased expression of PTGS2 mRNA]; Dactinomycin inhibits the reaction [Corticosterone results in increased expression of PTGS2 protein]; Mifepristone inhibits the reaction [Corticosterone promotes the reaction [NR3C1 protein binds to PTGS2 promoter]] Corticosterone results in increased expression of PTGS2 mRNA; Corticosterone results in increased expression of PTGS2 protein
[Corticosterone co-treated with PTH protein] results in decreased expression of TNFRSF11B mRNA; [Corticosterone co-treated with PTH protein] results in decreased expression of TNFSF11 mRNA
Corticosterone results in increased expression of SGK1 mRNA [Corticosterone results in increased phosphorylation of SGK1 protein] which results in increased phosphorylation of NDRG1 protein [Corticosterone results in increased phosphorylation of and results in increased activity of PDK1 protein] which results in increased phosphorylation of and results in increased activity of SGK1 protein Corticosterone results in increased expression of SGK1 mRNA; Corticosterone results in increased expression of SGK1 protein
Corticosterone results in increased expression of SLC18A3 protein O-1602 compound inhibits the reaction [Corticosterone results in increased expression of SLC18A3 protein]
Corticosterone inhibits the reaction [Hydrogen Peroxide results in decreased expression of SLC1A2 protein]; Vitamin A promotes the reaction [Corticosterone results in increased expression of SLC1A2 protein]
Corticosterone results in decreased activity of SLC22A3 protein [Corticosterone results in decreased activity of SLC22A3 protein] inhibits the reaction [Epinephrine results in increased abundance of Epinephrine metabolite]; [Corticosterone results in decreased activity of SLC22A3 protein] which results in decreased abundance of Epinephrine; [Corticosterone results in decreased activity of SLC22A3 protein] which results in decreased import of Phenylephrine; [Corticosterone results in decreased activity of SLC22A3 protein] which results in decreased import of Synephrine; Corticosterone inhibits the reaction [SLC22A3 protein results in increased transport of 1-Methyl-4-phenylpyridinium]; Corticosterone inhibits the reaction [SLC22A3 protein results in increased transport of Histamine]; Corticosterone inhibits the reaction [SLC22A3 protein results in increased uptake of Tetraethylammonium] Corticosterone inhibits the reaction [SLC22A3 protein results in increased import of 4-(4-(dimethylamino)styryl)-1-methylpyridinium iodide]; Corticosterone inhibits the reaction [SLC22A3 protein results in increased uptake of 1-Methyl-4-phenylpyridinium]; Corticosterone inhibits the reaction [SLC22A3 protein results in increased uptake of Formoterol Fumarate]
Corticosterone results in increased expression of SLC22A8 protein O-1602 compound inhibits the reaction [Corticosterone results in increased expression of SLC22A8 protein]
Corticosterone results in increased expression of SLC2A1 mRNA [Permethrin co-treated with Pyridostigmine Bromide co-treated with Corticosterone] results in increased expression of SLC2A1 mRNA; Butyric Acid inhibits the reaction [[Permethrin co-treated with Pyridostigmine Bromide co-treated with Corticosterone] results in increased expression of SLC2A1 mRNA]; TLR4 gene mutant form inhibits the reaction [[Permethrin co-treated with Pyridostigmine Bromide co-treated with Corticosterone] results in increased expression of SLC2A1 mRNA]
Corticosterone results in increased expression of SLC2A4 mRNA [Permethrin co-treated with Pyridostigmine Bromide co-treated with Corticosterone] results in increased expression of SLC2A4 mRNA; Butyric Acid inhibits the reaction [[Permethrin co-treated with Pyridostigmine Bromide co-treated with Corticosterone] results in increased expression of SLC2A4 mRNA]; TLR4 gene mutant form inhibits the reaction [[Permethrin co-treated with Pyridostigmine Bromide co-treated with Corticosterone] results in increased expression of SLC2A4 mRNA]
Edaravone inhibits the reaction [Corticosterone results in decreased expression of SLC6A15 mRNA]; Paroxetine inhibits the reaction [Corticosterone results in decreased expression of SLC6A15 mRNA]
[IGF2R protein co-treated with IGF1R protein] affects the reaction [IGF2 protein inhibits the reaction [Corticosterone results in decreased expression of SOD2 protein]]; IGF2 protein inhibits the reaction [Corticosterone results in decreased expression of SOD2 protein] Corticosterone results in decreased activity of SOD2 protein Corticosterone results in decreased expression of SOD2 mRNA; Corticosterone results in decreased expression of SOD2 protein
Corticosterone results in decreased expression of NPHS1 mRNA; Corticosterone results in decreased expression of NPHS1 protein HDAC7 protein affects the reaction [Corticosterone results in decreased expression of NPHS1 mRNA]; HDAC7 protein affects the reaction [Corticosterone results in decreased expression of NPHS1 protein]; KLF4 protein inhibits the reaction [Corticosterone results in decreased expression of NPHS1 mRNA]; KLF4 protein inhibits the reaction [Corticosterone results in decreased expression of NPHS1 protein]; Mifepristone inhibits the reaction [Corticosterone results in decreased expression of NPHS1 mRNA]; Mifepristone inhibits the reaction [Corticosterone results in decreased expression of NPHS1 protein]; trichostatin A inhibits the reaction [Corticosterone results in decreased expression of NPHS1 mRNA]; trichostatin A inhibits the reaction [Corticosterone results in decreased expression of NPHS1 protein]
[Corticosterone co-treated with oleoyl-estrone] affects the expression of SREBF1 mRNA [Permethrin co-treated with Pyridostigmine Bromide co-treated with Corticosterone] results in increased expression of SREBF1 mRNA; Butyric Acid inhibits the reaction [[Permethrin co-treated with Pyridostigmine Bromide co-treated with Corticosterone] results in increased expression of SREBF1 mRNA]; TLR4 gene mutant form inhibits the reaction [[Permethrin co-treated with Pyridostigmine Bromide co-treated with Corticosterone] results in increased expression of SREBF1 mRNA]
[Corticosterone co-treated with Isoflurophate] results in increased phosphorylation of STAT3 protein; [Corticosterone co-treated with O,O-diethyl O-3,5,6-trichloro-2-pyridyl phosphate] results in increased phosphorylation of STAT3 protein
Ascorbic Acid inhibits the reaction [Corticosterone results in decreased expression of SYN1 protein]; Ketamine inhibits the reaction [Corticosterone results in decreased expression of SYN1 protein]
[Mirex co-treated with Corticosterone] results in increased activity of TAT protein; Corticosterone promotes the reaction [[NR3C1 protein binds to TAT promoter] which results in increased expression of TAT mRNA]
Corticosterone inhibits the reaction [TGFB1 protein results in increased secretion of VEGFA protein] Corticosterone results in decreased expression of TGFB1 mRNA
Corticosterone results in decreased expression of TGFBR1 mRNA; Corticosterone results in decreased expression of TGFBR1 protein Mifepristone inhibits the reaction [Corticosterone results in decreased expression of TGFBR1 mRNA]
[Permethrin co-treated with Pyridostigmine Bromide co-treated with Corticosterone] results in increased expression of TLR4 protein; Butyric Acid inhibits the reaction [[Permethrin co-treated with Pyridostigmine Bromide co-treated with Corticosterone] results in increased expression of TLR4 protein]; TLR4 gene mutant form inhibits the reaction [[Permethrin co-treated with Pyridostigmine Bromide co-treated with Corticosterone] results in increased expression of PFKP mRNA]; TLR4 gene mutant form inhibits the reaction [[Permethrin co-treated with Pyridostigmine Bromide co-treated with Corticosterone] results in increased expression of PPARA mRNA]; TLR4 gene mutant form inhibits the reaction [[Permethrin co-treated with Pyridostigmine Bromide co-treated with Corticosterone] results in increased expression of SLC2A1 mRNA]; TLR4 gene mutant form inhibits the reaction [[Permethrin co-treated with Pyridostigmine Bromide co-treated with Corticosterone] results in increased expression of SLC2A4 mRNA]; TLR4 gene mutant form inhibits the reaction [[Permethrin co-treated with Pyridostigmine Bromide co-treated with Corticosterone] results in increased expression of SREBF1 mRNA]; TLR4 gene mutant form inhibits the reaction [[Permethrin co-treated with Pyridostigmine Bromide co-treated with Corticosterone] results in increased expression of TLR5 protein]
[Permethrin co-treated with Pyridostigmine Bromide co-treated with Corticosterone] results in increased expression of TLR5 protein; Butyric Acid inhibits the reaction [[Permethrin co-treated with Pyridostigmine Bromide co-treated with Corticosterone] results in increased expression of TLR5 protein]; TLR4 gene mutant form inhibits the reaction [[Permethrin co-treated with Pyridostigmine Bromide co-treated with Corticosterone] results in increased expression of TLR5 protein]
[Corticosterone co-treated with Isoflurophate] results in increased expression of TNF mRNA; [Corticosterone co-treated with O,O-diethyl O-3,5,6-trichloro-2-pyridyl phosphate] results in increased expression of TNF mRNA; [Corticosterone co-treated with Physostigmine] results in increased expression of TNF mRNA; [Corticosterone co-treated with Pyridostigmine Bromide] results in increased expression of TNF mRNA; [Permethrin co-treated with Pyridostigmine Bromide co-treated with Corticosterone] results in increased expression of TNF mRNA; Butyric Acid inhibits the reaction [[Permethrin co-treated with Pyridostigmine Bromide co-treated with Corticosterone] results in increased expression of TNF mRNA]; Corticosterone promotes the reaction [Isoflurophate results in increased expression of TNF mRNA]; Corticosterone promotes the reaction [O,O-diethyl O-3,5,6-trichloro-2-pyridyl phosphate results in increased expression of TNF mRNA] Corticosterone results in increased expression of TNF protein Corticosterone results in increased expression of TNF mRNA [Corticosterone co-treated with Isoflurophate] results in increased expression of TNF mRNA; O-1602 compound inhibits the reaction [Corticosterone results in increased expression of TNF protein]
Corticosterone results in decreased expression of TNFRSF11B mRNA Corticosterone results in increased expression of TNFRSF11B mRNA [Corticosterone co-treated with PTH protein] results in decreased expression of TNFRSF11B mRNA; Mifepristone inhibits the reaction [Corticosterone results in increased expression of TNFRSF11B mRNA]
[Corticosterone co-treated with PTH protein] results in decreased expression of TNFSF11 mRNA; Mifepristone inhibits the reaction [Corticosterone results in decreased expression of TNFSF11 mRNA] Corticosterone results in increased expression of TNFSF11 mRNA
[Testosterone co-treated with Estradiol co-treated with Corticosterone] promotes the reaction [AR protein binds to TRAF6 protein]; [Testosterone co-treated with Estradiol co-treated with Corticosterone] promotes the reaction [ESR1 protein binds to TRAF6 protein] 1,3-bis(4-hydroxyphenyl)-4-methyl-5-(4-(2-piperidinylethoxy)phenol)-1H-pyrazole inhibits the reaction [Estradiol inhibits the reaction [Corticosterone results in increased expression of TRAF6 protein]]; Corticosterone results in increased expression of and results in increased ubiquitination of TRAF6 protein; Estradiol inhibits the reaction [Corticosterone results in increased expression of and results in increased ubiquitination of TRAF6 protein]; Estradiol promotes the reaction [Testosterone inhibits the reaction [Corticosterone results in increased ubiquitination of TRAF6 protein]]; Flutamide inhibits the reaction [Estradiol inhibits the reaction [Corticosterone results in increased expression of TRAF6 protein]]; Testosterone inhibits the reaction [Corticosterone results in increased ubiquitination of TRAF6 protein]; Testosterone promotes the reaction [Estradiol inhibits the reaction [Corticosterone results in increased expression of and results in increased ubiquitination of TRAF6 protein]]
Corticosterone results in increased expression of TSC22D3 mRNA; Corticosterone results in increased expression of TSC22D3 protein TSC22D3 protein affects the reaction [Corticosterone results in decreased susceptibility to Doxorubicin]
Corticosterone inhibits the reaction [TGFB1 protein results in increased secretion of VEGFA protein] Corticosterone results in increased expression of VEGFA protein Corticosterone affects the expression of VEGFA protein
HSD11B1 protein results in increased metabolism of 11-dehydrocorticosterone HSD11B1 gene affects the susceptibility to 11-dehydrocorticosterone [HSD11B1 protein results in increased oxidation of Corticosterone] which results in increased chemical synthesis of 11-dehydrocorticosterone; [HSD11B1 protein results in increased reduction of 11-dehydrocorticosterone] which results in increased chemical synthesis of Corticosterone; Resveratrol inhibits the reaction [HSD11B1 protein results in increased metabolism of 11-dehydrocorticosterone]; Ziram inhibits the reaction [[HSD11B1 protein results in increased reduction of 11-dehydrocorticosterone] which results in increased chemical synthesis of Corticosterone]; Ziram inhibits the reaction [HSD11B1 protein results in increased reduction of 11-dehydrocorticosterone] HSD11B1 gene mutant form affects the abundance of 11-dehydrocorticosterone
[HSD11B2 protein results in increased metabolism of Corticosterone] which results in increased chemical synthesis of 11-dehydrocorticosterone; [HSD11B2 protein results in increased oxidation of Corticosterone] which results in increased chemical synthesis of 11-dehydrocorticosterone; Ziram inhibits the reaction [[HSD11B2 protein results in increased oxidation of Corticosterone] which results in increased chemical synthesis of 11-dehydrocorticosterone]
11-dehydrocorticosterone results in increased expression of IL6 mRNA 11-dehydrocorticosterone promotes the reaction [[trimethyltin chloride results in increased abundance of trimethyltin] which results in increased expression of IL6 mRNA]
Carbenoxolone inhibits the reaction [11-dehydrocorticosterone results in increased expression of SGK1 mRNA]; Tetradecanoylphorbol Acetate promotes the reaction [11-dehydrocorticosterone results in increased expression of SGK1 mRNA]